Literature DB >> 1313076

Adult adrenoleukodystrophy: the clinical spectrum in a large Dutch family.

C P Zwetsloot1, G W Padberg, A P van Seters, P D Maaswinkel-Mooy, W Onkenhout.   

Abstract

A large family with adrenoleukodystrophy is described and the case histories of two clinically symptomatic and related male patients are presented. Clinical, biochemical and genetic screening of their family demonstrated two clinically affected males, one biochemically affected male and five carrier females. Two women were symptomatic; one suffered an acute exacerbation. One female was diagnosed as a carrier, based on genetic analysis and the family history only. Endocrinological screening was performed in the five affected males, demonstrating an elevated adrenocorticotrophic hormone level and a normal cortisol level in two, as evidence of compensated adrenocortical failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313076     DOI: 10.1007/bf00862985

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Adrenoleukodystrophy in a mother and son.

Authors:  R H Simpson; J Rodda; C J Reinecke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

2.  Linkage analysis in X-linked adrenoleukodystrophy and application in post- and prenatal diagnosis.

Authors:  B A van Oost; P M van Zandvoort; W Tünte; H G Brunner; A J Hoogeboom; P D Maaswinkel-Mooy; J Bakkeren; B Hamel; H H Ropers
Journal:  Hum Genet       Date:  1991-02       Impact factor: 4.132

3.  Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy.

Authors:  T Miike; K Taku; T Tamura; J Ohta; M Ozaki; C Yamamoto; T Sakai; Y Antoku; C Yadomi
Journal:  Brain Dev       Date:  1989       Impact factor: 1.961

4.  Bromocriptine therapy for non-functioning pituitary adenoma.

Authors:  D van Schaardenburg; F Roelfsema; A P van Seters; G J Vielvoye
Journal:  Clin Endocrinol (Oxf)       Date:  1989-05       Impact factor: 3.478

5.  Progression of endocrinological and neurological dysfunction in adrenoleukodystrophy. Endocrinological evidence of an affection of the adrenal cortex independent of the cerebral disorder.

Authors:  A W de Weerd; A C van Huffelen; H M Reeser
Journal:  Eur Neurol       Date:  1982       Impact factor: 1.710

6.  Linkage of adrenoleukodystrophy to a polymorphic DNA probe.

Authors:  P R Aubourg; G H Sack; D A Meyers; J J Lease; H W Moser
Journal:  Ann Neurol       Date:  1987-04       Impact factor: 10.422

7.  Addison disease and cerebral sclerosis in an apparently heterozygous girl: evidence for inactivation of the adrenoleukodystrophy locus.

Authors:  W Heffungs; H Hameister; H H Ropers
Journal:  Clin Genet       Date:  1980-09       Impact factor: 4.438

8.  Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.

Authors:  H W Moser; A E Moser; I Singh; B P O'Neill
Journal:  Ann Neurol       Date:  1984-12       Impact factor: 10.422

9.  Nuclear magnetic resonance (NMR) imaging in white matter disease of the brain using spin-echo sequences.

Authors:  I R Young; C P Randell; P W Kaplan; A James; G M Bydder; R E Steiner
Journal:  J Comput Assist Tomogr       Date:  1983-04       Impact factor: 1.826

10.  Familial adrenoleukodystrophy: long chain fatty acid levels and analysis with a factor VIII DNA probe.

Authors:  S Berriche; J C Turpin; G Lucotte
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

View more
  2 in total

Review 1.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

2.  A family with adult-onset cerebral adrenoleucodystrophy.

Authors:  B Angus; R de Silva; R Davidson; I Bone
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.